|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Product sales and other | |||||
| Research and development services | |||||
| Total revenues | |||||
| Cost of revenues | |||||
| Product sales and other | |||||
| Research and development services | |||||
| Research and development services | |||||
| Total cost of revenues | |||||
| Gross profit | |||||
| Operating expenses | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Exit and termination costs | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest income | |||||
| Gain (loss) on impairment and disposal of assets | |||||
| Gain on disposal of assets | |||||
| Other income, net | |||||
| Net loss | |||||
| Net loss per share, basic (in dollars per share) | |||||
| Net loss per share, diluted (in dollars per share) | |||||
| Weighted-average shares outstanding, basic (in shares) | |||||
| Weighted-average shares outstanding, diluted (in shares) | |||||
Loading...